Neurofibromatosis 2: A Novel Risk Factor for Hypertension?

被引：8

作者：

Hornigold, Rachael E. ^{[1
]}

Golding, John F. ^{[2
]}

Ferner, Robin E. ^{[3
]}

Ferner, Rosalie E. ^{[1
]}

机构：

[1] Guys & St Thomas NHS Fdn Trust, London, England

[2] Univ Westminster, London W1R 8AL, England

[3] W Midlands Ctr Adverse Drug React, Birmingham, W Midlands, England

来源：

AMERICAN JOURNAL OF MEDICAL GENETICS PART A | 2011年 / 155A卷 / 07期

关键词：

neurofibromatosis; 2; hypertension; vasculopathy; BEVACIZUMAB; TYPE-2;

D O I：

10.1002/ajmg.a.34035

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

There are anecdotal reports of neurofibromatosis 2 (NF2) patients and vascular disease, but no previous studies have compared blood pressure (BP) in people with NF2 and in the general population. This study is the first to show that BP is significantly higher in patients with NF2 than in matched control patients. This is important for the management of patients with NF2, and in the differential diagnosis of secondary hypertension. (C) 2011 Wiley-Liss, Inc.

引用

收藏

页码：1721 / 1722

页数：2

相关论文

共 12 条

[1] Predictors of the risk of mortality in neurofibromatosis 2 [J].

Baser, ME ;

Friedman, JM ;

Aeschliman, D ;

Joe, H ;

Wallace, AJ ;

Ramsden, RT ;

Evans, DGR .

AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) :715-723

[2] WIDESPREAD BUT CELL-TYPE-SPECIFIC EXPRESSION OF THE MOUSE NEUROFIBROMATOSIS TYPE-2 GENE [J].

CLAUDIO, JO ;

LUTCHMAN, M ;

ROULEAU, GA .

NEUROREPORT, 1995, 6 (14) :1942-1946

[3] Renal vascular disease in neurofibromatosis type 2: association or coincidence? [J].

Cordeiro, NJV ;

Gardner, KR ;

Huson, SM ;

Stewart, H ;

Elston, JS ;

Howard, EL ;

Tullus, KO ;

Pike, MG .

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (01) :58-59

[4] Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: Higher incidence than previously thought [J].

Evans, DGR ;

Moran, T ;

King, A ;

Saeed, S ;

Gurusinghe, J ;

Ramsden, R .

OTOLOGY & NEUROTOLOGY, 2005, 26 (01) :93-97

[5] Neuro-fibromatosis 1 and neuro-fibromatosis 2: a twenty first century perspective [J].

Ferner, Rosalie E. .

LANCET NEUROLOGY, 2007, 6 (04) :340-351

[6] Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis [J].

Kwon, HJ ;

Kim, MS ;

Kim, MJ ;

Nakajima, H ;

Kim, KW .

INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (03) :290-296

[7]

Lesley WS, 2004, AM J NEURORADIOL, V25, P1414

[8] Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2 [J].

Mautner, Victor-Felix ;

Nguyen, Rosa ;

Kutta, Hannes ;

Fuensterer, Carsten ;

Bokemeyer, Carsten ;

Hagel, Christian ;

Friedrich, Reinhard E. ;

Panse, Jens .

NEURO-ONCOLOGY, 2010, 12 (01) :14-18

[9] Cardiac side-effects of cancer chemotherapy [J].

Monsuez, Jean-Jacques ;

Charniot, Jean-Christophe ;

Vignat, Noelle ;

Artigou, Jean-Yves .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (01) :3-15

[10] Stroke in a child with neurofibromatosis type 2 [J].

Ng, Joanne ;

Mordekar, Santosh R. ;

Connolly, Daniel J. A. ;

Baxtera, Peter .

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2009, 13 (01) :77-79